The #1 Stock for the Global Energy Crisis ⚡

Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, guys and gals. It's Chris from Elite Trade Club, here to give you the day's premarket trading news. Today is Thursday, September 8th. Let's get ready to trade! Markets 📈 The S&P 500 added 1.8% on Wednesday, while the Dow gained 1.4%. The Nasdaq rallied 2.1%, and the small-cap Russell 2K advanced 2.2% on the session. Today, futures are wobbling after yesterday's rebound rally. S&P 500 contracts are currently showing a 0.2% gain. Sponsored [The #1 Stock for the Global Energy Crisis ⚡]( International conflict has thrown global energy markets into utter chaos, but one tiny company could be in a prime position to capitalize. Analysts are beginning to take notice of the opportunity, and some price targets call for potential gains as high as 400%. Demand is already beginning to soar for this firm’s cutting-edge energy storage solutions, which could be the key to solving the global energy crisis. Shares are currently trading for cheap, but the big breakout could be right around the corner. [Get the Ticker Here and Make Your Move Before It Takes Of]( Premarket Highlights 🔎 - The U.S. announces another $2.6 billion in military assistance to Ukraine and neighboring countries. - Apple introduced the iPhone 14 yesterday, and shares climbed 0.9% in the wake of the new release. What to Watch Today 👀 Powell Speaks Fed Chairman Jerome Powell will speak today at 9:10 a.m., Eastern time. His speech could spark volatility in today's trading session. Also, keep an eye out for this week's jobless claims numbers because it good sway investor sentiment in today's trading session. International 🌍 Asia Japan's Nikkei 225 rallied 2.3% overnight, while Hong Kong's Hang Seng Composite tumbled 1.0%. Australia's ASX 200 spiked 1.8%. Europe The German DAX is down 0.3%, but the FTSE 100 and the Euro Stoxx 600 are both showing a 0.2% gain. France's CAC 40 is up 0.4%. Major Earnings 💰 Bilibili [BILI] ... AM FuelCell Energy [FCEL] ... AM Bioceres Crop Solutions [BIOX] ... AM Zscaler [ZS] ... PM DocuSign [DOCU] ... PM RH [RH] ... PM Sprinklr [CXM] ... PM Mission Produce [AVO] ... PM Smith & Wesson Brands [SWBI] ... PM Zumiez [ZUMZ] ... PM Economy 🏗 - Initial jobless claims [Sep] ... 8:30a - Continuing jobless claims [Aug] ... 8:30a - Average consumer expenditures [2021] ... 10a - Quarterly services survey [Q2] ... 10a - Consumer credit [Jul] ... 3p Running Hot 🔥 Gainers - AcelRX [ACRX] >> +11.1% - Revance Theraputics [RVNC] >> +16.7% - VivoPower Intl. [VVPR] >> +15.2% Decliners - Chembio [CEMI] >> (13.8%) - Ricebran Tech [RIBT] >> (15.9%) - American Eagle Outfitters [AEO] >> (13.4%) MarketAxess Holdings [MKTX] - Last Close: $247.72 MarketAxess is rebounding after setting a new yearly low. Yesterday, the electronic trading platform firm set a new 52-week low when it fell to $235.42 early in the trading session. However, the stock rebounded to close with a 2.1% gain after Broadway Technology announced it had partnered with MarketAxess to bring integrated US Treasury trading to the platform. The rally didn't end at the closing bell, either. Shares of MKTX continued their rebound in today's premarket. MKTX is leading the S&P 500 with a 3.3% gain. My Take: MKTX has an elevated P/E, but it's trading along solid support at around $250. This rally could help it break out of its funk Amylyx Pharmaceuticals [AMLX] - Last Close: $17.90 A favorable regulatory ruling is boosting shares of Amylyx Pharma. On Wednesday evening, the company announced that a key US Food & Drug Administration panel recommended approval for its AMX0035 drug candidate as a treatment of ALS. The FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted seven-to-two to support the drug's approval. The vote isn't binding, but it will be considered when regulators weigh whether to grant the drug candidate a full approval. Amylyx says the Prescription Drug User Fee Act target action date for the application is on Sept. 29. AMLX is trading actively with a 83.7% gain on the news. My Take: Investors seem to be betting that the panel's ruling all but assures Amylyx will get its approval, but shares could plummet if they're wrong. Furthermore, an approval is largely priced in at this point, so there could be limited upside at the current price point. Asana Inc [ASAN] - Last Close: $19.04 Asana is trending after releasing its quarterly earnings report. The project management software firm released its fiscal Q2 results on Wednesday evening, and shares are rallying in the wake of the release. Asana's posted a wider Q2 loss of ($0.34) per share after reporting a ($0.23) per share loss a year earlier. However, it nonetheless beat the Street's target of a ($0.39) per share. The company posted revenues of $134.9 million for the quarter, marking significant growth from last year, and easily beating Wall Street's $127.3 million revenue target. Asana also hiked its full-year fiscal 2023 guidance to a better-than-expected range of $544 million to $547 million in response to the stronger-than-expected quarter. ASAN is trading actively with a 23.5% gain on the news. My Take: Asana makes a great product, and today's rally could help it break out of a long-term slump. However, the firm's lack of profitability is a concern, especially in a tough economic environment. I like this stock, but time your entry points wisely to avoid potential losses. Eve Holding Inc [EVEX] - Last Close: $6.16 Eve Holding just landed a blockbuster deal with a powerful partner. United Airlines announced this morning that it has invested $15 million into Eve Air Mobility and ordered 200 air taxis from the high-tech startup. The deal includes an option that would allow United to purchase 200 more of Eve's four-seater air taxis, AKA electric vertical take-off and landing vehicles (eVTOLs). The airline said it expects to receive delivery of its first Eve aircraft sometime in 2026. Eve's eVTOL has a range of 60 miles, but the company hasn't received clearance to fly passengers yet. Regardless, news of the United deal shows airlines are very interested in adding Eve's aircraft to its fleet. EVEX is one of today's top performers with a 21.8% gain. My Take: Investors are hopeful that Eve's United deal could be the first of many deals with US airlines. If they're right, there could be many more catalysts in this stock's future. However, it will be years before EVEX starts making deliveries, and a lot can go wrong in that time. The risks are there, but it could be a good speculative play. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](